Director James Caruso receives 40,000 VTAK options at $1.15 exercise price

Rhea-AI Filing Summary

Catheter Precision, Inc. director James Joseph Caruso received a grant of options to buy 40,000 shares of common stock. The options have an exercise price of $1.15 per share and expire on March 26, 2036. According to the grant terms, the options vest 100% on the 180-day anniversary of the grant date.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Caruso James Joseph

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Options (Right to Buy)	40,000	$0.00	--

Holdings After Transaction: Options (Right to Buy) — 40,000 shares (Direct)

Footnotes (1)

1. [object Object]

Key Figures

Options granted: 40,000 options Exercise price: $1.15 per share Expiration date: March 26, 2036 +1 more

4 metrics

Options granted 40,000 options Grant to director James Joseph Caruso on March 26, 2026

Exercise price $1.15 per share Strike price for the 40,000 options

Expiration date March 26, 2036 Option term for director grant

Post-grant derivative holdings 40,000 options Total options held after the reported transaction

Key Terms

Options (Right to Buy), exercise price, vest 100% on 180 day anniversary, expiration date

4 terms

Options (Right to Buy) financial

"security_title: "Options (Right to Buy)""

exercise price financial

"conversion_or_exercise_price: "1.1500""

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

vest 100% on 180 day anniversary financial

"Options vest 100% on 180 day anniversary of grant date."

expiration date financial

"expiration_date: "2036-03-26T00:00:00.000Z""

The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Caruso James Joseph

(Last) (First) (Middle)

1670 HIGHWAY 160 WEST

SUITE 205

(Street)

FORT MILL SOUTH CAROLINA 29708

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Catheter Precision, Inc. [ VTAK ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/26/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Options (Right to Buy)	$1.15	03/26/2026		A		40,000		(1)	03/26/2036	Common Stock	40,000	$0	40,000	D

Explanation of Responses:

1. Options vest 100% on 180 day anniversary of grant date.

	/s/ James J Caruso	03/30/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did VTAK director James Caruso report?

James Joseph Caruso reported receiving options to buy 40,000 shares of Catheter Precision common stock. This was a compensation-related grant, not an open-market purchase, and increases his potential future ownership if the options vest and are exercised.

What is the exercise price of James Caruso’s new VTAK stock options?

The options granted to James Caruso have an exercise price of $1.15 per share. This means he can buy Catheter Precision common stock at $1.15 if he exercises the options after they vest, subject to the grant’s terms and expiration date.

How many VTAK options does James Caruso hold after this Form 4 filing?

Following the reported grant, James Caruso holds 40,000 stock options in Catheter Precision. These options give him the right to purchase an equal number of common shares if exercised, reflecting his full derivative position disclosed in this filing.

When do James Caruso’s Catheter Precision options vest and expire?

The options granted to James Caruso vest 100% on the 180-day anniversary of the grant date. They expire on March 26, 2036, giving a long window for potential exercise once vesting conditions are satisfied under the award terms.

Is James Caruso’s Form 4 for VTAK a stock sale or a grant?

The Form 4 reports a grant of options to James Caruso, classified as an acquisition under transaction code A. It does not disclose any open-market sale or purchase of Catheter Precision common stock, only this new option award position.